News
Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”, “the Company”) today announces that its next-generation PSMA-PET imaging 1 agent for prostate cancer, Gozellix® (kit for the preparation ...
The Food and Drug Administration (FDA) has approved Xifyrm ™ (meloxicam injection) for use in adults for the management of moderate to severe pain, alone or in combination with non-NSAID ...
Combination vaccines are recommended by health authorities worldwide to reduce the number of jabs given to children while ...
A Cleveland Clinic study shows that semaglutide and tirzepatide—injectable GLP-1 drugs for obesity—produce smaller weight ...
Treatment with retifanlimab plus carboplatin-paclitaxel statistically significantly reduced the risk of progression or death by 37% compared with placebo plus carboplatin-paclitaxel.
Combining TTFields with gemcitabine and nab-paclitaxel can improve OS in patients with locally advanced pancreatic adenocarcinoma, results of the PANOVA-3 trial suggest.
Adding relacorilant to nab-paclitaxel improved survival outcomes in patients with platinum-resistant ovarian cancer.
Biontech SE and Bristol Myers Squibb Co. are teaming up to develop Biontech’s bispecific antibody targeting PD-L1 and VEGF-A, BNT-327, in a deal possibly worth over $11 billion. The companies will ...
Mabwell (688062.SH), an innovation-driven biopharmaceutical company with entire industry chain, announced that Albipagrastim alfa for Injection (trade name: MAILISHENG, R&D code: 8MW0511) developed by ...
- Data to be reviewed during a Key Opinion Leader webinar Featuring Dr. Manuel Hidalgo Medina and Dr. Mike Pishvaian on Wednesday May 7th, 2025 at 0800 US EDT - ROCKVILLE, Md., May 07, 2025 (GLOBE ...
Dublin, March 27, 2025 (GLOBE NEWSWIRE) -- The "Paclitaxel Injection Market Report 2025"has been added to ResearchAndMarkets.com's offering. This report covers market characteristics, size and ...
Dublin, March 27, 2025 (GLOBE NEWSWIRE) -- The "Paclitaxel Injection Market Report 2025"has been added to ResearchAndMarkets.com's offering. This report covers market characteristics, size and growth, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results